The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Clarification of the Risk of Chronic Obstructive Pulmonary Disease in α 1 -Antitrypsin Deficiency PiMZ Heterozygotes
Open accessAbstract
RATIONALE: Severe α1-antitrypsin deficiency (typically PiZZ homozygosity) is associated with a significantly increased risk of airflow obstruction and emphysema but the risk of chronic obstructive pulmonary disease (COPD) in PiMZ heterozygotes remains uncertain. OBJECTIVES: This was a family-based study to determine the risk of COPD in PiMZ individuals. METHODS: We compared 99 PiMM and 89 PiMZ nonindex subjects recruited from 51 index probands who were confirmed PiMZ heterozygotes and also had a diagnosis of COPD Global Initiative for Chronic Obstructive Lung Disease stage II-IV. The primary outcome measures of interest were quantitative variables of pre- and post-bronchodilator FEV1/FVC ratio, FEV1 (liters), FEV1 (% predicted), forced expiratory flow midexpiratory phase (FEF25-75; liters per second), FEF25-75 (% predicted), and a categorical outcome of COPD. MEASUREMENTS AND MAIN RESULTS: PiMZ heterozygotes compared with PiMM individuals had a reduced median (interquartile range) post-bronchodilator FEV1 (% predicted) (92.0 [75.6-105.4] vs. 98.6 [85.5-109.7]; P = 0.04), FEV1/FVC ratio (0.75 [0.66-0.79] vs. 0.78 [0.73-0.83]; P = 0.004), and FEF25-75 (% predicted) (63.84 [38.45-84.35] vs. 72.8 [55.5-97.7]; P = 0.0013) compared with PiMM individuals. This effect was abrogated in never-smoking and accentuated in ever-smoking PiMZ individuals. PiMZ heterozygosity was associated with an adjusted odds ratio for COPD of 5.18 (95% confidence interval, 1.27-21.15; P = 0.02) and this was higher (odds ratio, 10.65; 95% confidence interval, 2.17-52.29; P = 0.004) in ever-smoking individuals. CONCLUSIONS: These results indicate that PiMZ heterozygotes have significantly more airflow obstruction and COPD than PiMM individuals and cigarette smoke exposure exerts a significant modifier effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Taggart, C., Cervantes-Laurean, D., Kim, G., McElvaney, N. G., Wehr, N., Moss, J., & Levine, R. L. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61505-x · Cited by 269
Self-citationHubbard, R. C., Ogushi, F., Fells, G. A., Cantin, A. M., Jallat, S., Courtney, M., & Crystal, R. G. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113204 · Cited by 157 · cited 1×
“Oxidants in cigarette smoke and those spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of AAT (notably methionine residue: 358), rendering it ineffective as an inhibitor of NE (24, 25).”
Background
Cited by
Chronic obstructive pulmonary disease
Barnes, P. J., Burney, P. G. J., Silverman, E. K., Celli, B. R., Vestbo, J., Wedzicha, J. A., & Wouters, E. F. M. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.76 · Cited by 734
Self-citationAlpha 1 -Antitrypsin Deficiency
Strnad, P., McElvaney, N. G., & Lomas, D. A. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1910234 · Cited by 515
Self-citationChapman, K. R., Burdon, J. G. W., Piitulainen, E., Sandhaus, R. A., Seersholm, N., Stocks, J. M., Stoel, B. C., Huang, L., Yao, Z., Edelman, J. M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60860-1 · Cited by 514
Self-citationGreene, C. M., Marciniak, S. J., Teckman, J., Ferrarotti, I., Brantly, M. L., Lomas, D. A., Stoller, J. K., & McElvaney, N. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.51 · Cited by 324
Self-citation
Metadata
- Authors
- Molloy, K., Hersh, C. P., Morris, V. B., Carroll, T. P., O’Connor, C. A., Lasky-Su, J. A., Greene, C. M., O’Neill, S. J., Silverman, E. K., & McElvaney, N. G.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-02-15
- Volume
- 189
- Issue
- 4
- Pages
- 419-427
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2047545735
- Cited by
- 181
- References
- 2
- FWCI
- 12.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clarification of the Risk of Chronic Obstructive Pulmonary Disease in α 1 -Antitrypsin Deficiency PiMZ Heterozygotes. https://app.cochat.ai/papers/10.1164/rccm.201311-1984oc
- The paper
- Molloy, K., Hersh, C. P., Morris, V. B., Carroll, T. P., O’Connor, C. A., Lasky-Su, J. A., Greene, C. M., O’Neill, S. J., Silverman, E. K., & McElvaney, N. G. (2014). Clarification of the Risk of Chronic Obstructive Pulmonary Disease in α 1 -Antitrypsin Deficiency PiMZ Heterozygotes. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201311-1984oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.